A Novel Approach in the Evaluation of Breast Masses With Doppler US
A Novel Approach to the Evaluation of Breast Masses Using Doppler Ultrasonography: Percentage Changes in Resistive Index Between the Mass and Surrounding Normal Parenchyma in Benign-Malignant Differentiation
1 other identifier
observational
90
1 country
1
Brief Summary
In cases with breast masses, Doppler resistive index values will be calculated for the mass and surrounding healthy tissue and the opposite healthy breast tissue, and their effect on distinguishing between benign and malignant masses will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2026
CompletedFirst Submitted
Initial submission to the registry
March 6, 2026
CompletedFirst Posted
Study publicly available on registry
March 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2026
CompletedMarch 16, 2026
March 1, 2026
2 months
March 6, 2026
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A Novel Approach to the Evaluation of Breast Masses Using Doppler Ultrasonography: Percentage Changes in Resistive Index Between the Mass and Surrounding Normal Parenchyma in Benign-Malignant Differentiation
ROC curve analysis will be applied for the diagnostic performance of relative RI change in benign and malignant lesions.
3-4 months
Eligibility Criteria
The study population will consist of female patients over the age of 18 who underwent breast biopsy in the radiology department due to a solid lesion in the breast.
You may qualify if:
- Those with solid breast masses
- Female patients
- Those with pathology results
You may not qualify if:
- Hypovascular masses
- Cystic breast masses
- Cases with mastitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ahmet Yesildaglead
Study Sites (1)
Karamanoğlu Mehmetbey University, KEAH
Karaman, Lütfen Seçiniz., 70200, Turkey (Türkiye)
Related Publications (3)
Choi HY, Kim HY, Baek SY, Kang BC, Lee SW. Significance of resistive index in color Doppler ultrasonogram: differentiation between benign and malignant breast masses. Clin Imaging. 1999 Sep-Oct;23(5):284-8. doi: 10.1016/s0899-7071(99)00152-7.
PMID: 10665344BACKGROUNDNiu J, Ma J, Guan X, Zhao X, Li P, Zhang M. Correlation Between Doppler Ultrasound Blood Flow Parameters and Angiogenesis and Proliferation Activity in Breast Cancer. Med Sci Monit. 2019 Sep 19;25:7035-7041. doi: 10.12659/MSM.914395.
PMID: 31535669BACKGROUNDMehta TS, Raza S, Baum JK. Use of Doppler ultrasound in the evaluation of breast carcinoma. Semin Ultrasound CT MR. 2000 Aug;21(4):297-307. doi: 10.1016/s0887-2171(00)90024-6.
PMID: 11014252BACKGROUND
Study Officials
- STUDY DIRECTOR
Ahmet Yeşildağ, Prof.Dr.
Karamanoğlu Mehmetbey Universty
- STUDY DIRECTOR
Ahmet Yeşildağ, Prof.Dr.
Karamanoğlu Mehmetbey University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
March 6, 2026
First Posted
March 12, 2026
Study Start
March 4, 2026
Primary Completion
May 5, 2026
Study Completion
May 19, 2026
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share